Novel MYC-Targeting Drug Is Effective in Mouse Prostate Cancer Models.
Publication
, Journal Article
Published in: Cancer Discov
January 2020
A new MYC inhibitor reduced tumor growth in mouse prostate cancer models.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Cancer Discov
DOI
EISSN
2159-8290
Publication Date
January 2020
Volume
10
Issue
1
Start / End Page
15
Location
United States
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Novel MYC-Targeting Drug Is Effective in Mouse Prostate Cancer Models. (2020). Cancer Discov, 10(1), 15. https://doi.org/10.1158/2159-8290.CD-RW2019-167
“Novel MYC-Targeting Drug Is Effective in Mouse Prostate Cancer Models.” Cancer Discov 10, no. 1 (January 2020): 15. https://doi.org/10.1158/2159-8290.CD-RW2019-167.
Novel MYC-Targeting Drug Is Effective in Mouse Prostate Cancer Models. Cancer Discov. 2020 Jan;10(1):15.
“Novel MYC-Targeting Drug Is Effective in Mouse Prostate Cancer Models.” Cancer Discov, vol. 10, no. 1, Jan. 2020, p. 15. Pubmed, doi:10.1158/2159-8290.CD-RW2019-167.
Novel MYC-Targeting Drug Is Effective in Mouse Prostate Cancer Models. Cancer Discov. 2020 Jan;10(1):15.
Published In
Cancer Discov
DOI
EISSN
2159-8290
Publication Date
January 2020
Volume
10
Issue
1
Start / End Page
15
Location
United States
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis